PHARMACEUTICAL COMPOSITIONS OF (R)-1-(2,2-DIFLUOROBENZO[D] [1,3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL) CYCLOPROPANECARBOXAMIDE AND ADMINISTRATION THEREOF
申请人:Alargova Rossitza Gueorguieva
公开号:US20120046330A1
公开(公告)日:2012-02-23
A pharmaceutical composition comprising Compound 1, (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering the pharmaceutical composition of Compound 1 are also disclosed.
一种包括化合物1、(R)-1-(2,2-二氟苯并[d][1,3]二噁英-5-基)-N-(1-(2,3-二羟丙基)-6-氟-2-(1-羟基-2-甲基丙烷基)-1H-吲哚-5-基)环丙烷甲酰胺的制药组合物,以及至少一种所选的辅料,包括:填料、稀释剂、分散剂、表面活性剂、润滑剂和润滑剂,该组合物适用于口服给予患有CFTR介导的疾病,如囊性纤维化症的患者。还公开了治疗需要的患者的方法,包括给予化合物1的制药组合物。